Ainos Inc
NASDAQ:AIMD

Watchlist Manager
Ainos Inc Logo
Ainos Inc
NASDAQ:AIMD
Watchlist
Price: 1.982 USD -1.39% Market Closed
Market Cap: 9.5m USD

Operating Margin
Ainos Inc

-12 678.1%
Current
-15 050%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-12 678.1%
=
Operating Profit
-14.3m
/
Revenue
113k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Ainos Inc
NASDAQ:AIMD
9.5m USD
-12 678%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
406.3B USD
33%
US
Amgen Inc
NASDAQ:AMGN
179.7B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
156.1B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.5B USD
28%
AU
CSL Ltd
ASX:CSL
83B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD
8%
NL
argenx SE
XBRU:ARGX
44B EUR
22%
No Stocks Found

Ainos Inc
Glance View

Market Cap
9.5m USD
Industry
Biotechnology

Ainos, Inc. engages in the discovery and development of pharmaceutical and biotech products. The company is headquartered in San Diego, California and currently employs 34 full-time employees. The firm is researching for the treatment of human disease indications, including Sjogren’s syndrome, thrombocytopenia, and other indications using interferon-alpha. The firm is also developing and manufacturing point-of-care testing rapid test kit products that include diagnostics for COVID-19, pneumonia, vaginal infection and helicobacter pylori bacterial infection. Its business units include Pharmaceutical, Medical Devices and Preventive Medicine Divisions. Pharmaceutical Division is focused on low-dose, orally administered lozenges containing the natural immune system activator interferon-alpha as a treatment for a variety of disease indications. Medical Device Division is developing an insulin pump and further development of point-of-care rapid test kits for the detection and diagnosis of human infections. Preventative Medicine Division is focused on SRNA-based therapeutics.

AIMD Intrinsic Value
0.207 USD
Overvaluation 90%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-12 678.1%
=
Operating Profit
-14.3m
/
Revenue
113k
What is the Operating Margin of Ainos Inc?

Based on Ainos Inc's most recent financial statements, the company has Operating Margin of -12 678.1%.

Back to Top